期刊文献+

唐方辨治慢性阻塞性肺疾病合并肺心病临床经验 被引量:4

Clinical Experience by Professor Tang Fang on Treating Chronic Obstructive Pulmonary Disease with Syndrome Differentiation and Treatment
暂未订购
导出
摘要 "三脏分治"紧抓主症,用药考究,灵活加减,中西医结合是唐方教授治疗慢性阻塞性肺疾病合并肺心病的思想精髓。通过分析临床实际案例进一步阐述唐老师临床治疗经验,为临床诊治疾病提供有益借鉴。 The essence of the experience by Professor Tang Fang on treating chronic obstructive pulmonary disease is to aim at the major symptoms through "treating 3 zang-organs respectively",to prescribe after careful consideration,modify with flexibility,and to combine traditional Chinese medicine with western medicine. Through analysis of clinical case clinical experience by Professor Tang was elaborated,to provide a useful reference for clinical diagnosis and treatment.
作者 张强 唐方
出处 《山东中医杂志》 2018年第1期54-57,共4页 Shandong Journal of Traditional Chinese Medicine
基金 天津市中医药管理局中西医结合科研课题(编号:13179)
关键词 慢性阻塞性肺疾病合并肺心病 唐方 临床经验 chronic obstructive pulmonary disease complicated with pulmonary heart disease Tang Fang clinical experience
  • 相关文献

参考文献2

二级参考文献32

  • 1陈建,王广发.慢性阻塞性肺疾病全球倡议2011修订版解读[J].中国医学前沿杂志(电子版),2012,4(1):42-44. 被引量:65
  • 2Global strategy for the diagnosis, management and pre- vention of chronic obstructive pulmonary disease (upda- ted 2015)[EB/OL]. 2015-Ol[2015-06-04].http://www.gold- copd.org/guidelines-globalstrategy-for-diagnosis-manage- ment.html.
  • 3Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma[J]. Proc Am Thorac Soc,2004,1 (2):136- 142.
  • 4Kew KM, Mavergames C, Wahers JA. Long-acting beta2- agonists for chronic obstructive pulmonary disease [J]. Cochrane Database Syst Rev,2013,10:CD010177.
  • 5Zheng JP, Wen FQ, Bai CX, et al. Twice daily N-acetyl- cysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double- blind placebo-controlled trial[J]. Lancet Respir Med,2014, 2(3):187-194.
  • 6Poole P, Black PN, Cares CJ. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary di- sease[J]. Cochrane Database Syst Rev,2012,8:CD001287.
  • 7Tse HN, Raiteri L, Wong KY, et al. High-dose N-acetyl- cysteine in stable COPD: the 1-year, double-blind, ran- domized, placebo-controlled HIACE study[J]. Chest,2013, 144(1):106-118.
  • 8Lundback BLM, Andersson S. Possible effect of acetyl- cysteine on lung function[J]. Eur Respir J,1992,5 (Suppl 15):895.
  • 9Decramer M, Rutten-van Mt~lken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial[J]. Lancet,2005,365(9470):1552- 1560.
  • 10Marjanovi6 N, Bosnar M, Michielin F, et al. Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro[J]. Pharmacol Res,2011,63(5):389-397.

共引文献11

同被引文献44

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部